Atlas Trials

Effect of Insulin Sensitizer Metformin on AD Biomarkers

Clinical trial NCT01965756 · COMPLETED

Trial details

NCT number
NCT01965756
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's DiseaseVascular DementiaDementiaMemory Impairment
Start date
2013-01-01
Primary completion
2015-12-22
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.